We are live on ! Find out more
OXFD

Oxford Immunotec Global PLC Ordinary Shares
OXFD

Delisted

OXFD was delisted on the 5th of March, 2021.

Back to rankings

77 hedge funds and large institutions have $337M invested in Oxford Immunotec Global PLC Ordinary Shares in 2017 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 32 increasing their positions, 26 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 26

3% less funds holding

Funds holding: 79 → 77 (-2)

13% less capital invested

Capital invested by funds: $385M → $337M (-$48.3M)

17% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 12

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
77
Holders Change
-2
Holders Change %
-2.53%
% of All Funds
1.75%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
10
Increased
32
Reduced
26
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
+$16.4M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$7.42M
3
DM
Deerfield Management
New York
+$4.66M
4
RG
Redmile Group
California
+$3.91M
5
Millennium Management
Millennium Management
New York
+$2.13M

Top Sellers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
-$9.62M
2
DCM
Driehaus Capital Management
Illinois
-$4.8M
3
SCM
Stonepine Capital Management
Oregon
-$2.73M
4
CCI
Columbus Circle Investors
-$2.64M
5
ECM
Endurant Capital Management
California
-$2.36M
Name Holding Trade Value Shares
Change 		Change in
Stake
PHK
76
Point72 Hong Kong
Hong Kong
$5K +$5.38K +367 New
DCM
77
Delpha Capital Management
New York
$1K +$1.16K +79 New
DCM
78
Driehaus Capital Management
Illinois
– -$4.8M -285,687 Closed
SCM
79
Stonepine Capital Management
Oregon
– -$2.73M -162,286 Closed
CCI
80
Columbus Circle Investors
– -$2.64M -157,123 Closed
EIM
81
Essex Investment Management
Massachusetts
– -$2.33M -139,009 Closed
EI
82
EAM Investors
California
– -$2.02M -120,397 Closed
SC
83
Scholtz & Company
Connecticut
– -$990K -58,925 Closed
AC
84
Ascend Capital
California
– -$868K -51,655 Closed
PCM
85
Prelude Capital Management
New York
– -$294K -17,482 Closed
CS
86
Credit Suisse
Switzerland
– -$250K -14,898 Closed
NFA
87
Nationwide Fund Advisors
Ohio
– -$213K -12,689 Closed
Bank of Montreal
88
Bank of Montreal
Ontario, Canada
– -$160K -9,492 Closed
TRCT
89
Tower Research Capital (TRC)
New York
– -$116K -6,912 Closed
1 2 3
4

OXFD Hedge Fund Activity: Q4 2017 in Review

77 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Oxford Immunotec Global PLC Ordinary Shares (OXFD) for Q4 2017, worth a combined $337M — down 13% from $385M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of OXFD and 10 opened new positions — a net loss of 2 holders — while 26 trimmed existing stakes and 32 added.

The largest buyer was Consonance Capital Management, opening a new position worth an estimated $16.4M. The largest seller was RTW Investments, cutting an estimated $9.62M.

  • 77 institutional investors held Oxford Immunotec Global PLC Ordinary Shares (OXFD) as of Q4 2017, down from 79 in Q3 2017.
  • Funds reported $337M of Oxford Immunotec Global PLC Ordinary Shares stock for Q4 2017, down 13% quarter-over-quarter.
  • 10 funds opened new Oxford Immunotec Global PLC Ordinary Shares positions in Q4 2017 and 12 closed out, a net change of -2 holders.
  • The largest Oxford Immunotec Global PLC Ordinary Shares buyer in Q4 2017 was Consonance Capital Management, an estimated $16.4M added.
  • The largest Oxford Immunotec Global PLC Ordinary Shares seller in Q4 2017 was RTW Investments, an estimated $9.62M sold.

Based on aggregated 13F filings for Q4 2017.